1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (6438)
  2. Meeting Abstract (5172)
  3. Review (332)
  4. Book Section (310)
  5. Editorial (92)
  6. Research Letter (73)
  7. Guidelines (52)
  8. Correspondence (47)
  9. Conference Paper (38)
  10. Miscellaneous (37)
  11. Book Whole (24)
Groups
  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Victor Reuter (1228)
  3. Cristina Antonescu (895)
  4. Michael Berger (765)
  5. William Travis (743)
  6. Jinru Shia (719)

More People

Years
  1. 2025 (307)
  2. 2024 (719)
  3. 2023 (766)
  4. 2022 (841)
  5. 2021 (677)
  6. 2020 (787)

More Years

Publications
  1. Laboratory Investigation (1448)
  2. Modern Pathology (1440)
  3. Journal of Clinical Oncology (863)
  4. American Journal of Surgical Pathology (429)
  5. Cancer Research (426)
  6. Blood (349)

More Publications

Publishers
  1. Nature Publishing Group (1939)
  2. Nature Research (1457)
  3. Elsevier Inc. (1139)
  4. American Society of Clinical Oncology (955)
  5. American Association for Cancer Research (923)
  6. Lippincott Williams & Wilkins (896)

More Publishers

Results (12615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MR detection of mammographically occult DCIS
    Meeting Abstract

    Menell, J. H.; Morris, E. A.; Dershaw, D. D.; Abramson, A. F.; Brogi, E.; Bartella, L.; Liberman, L.
    American Journal of Roentgenology (2004)

    Fulltext@MSK | Save
  • Primary peritoneal mesothelioma: How aggressive should we be?
    Meeting Abstract

    Labow, D. M.; Coit, D. G.; Kelsen, D.; Shia, J.; Freeman, S.; Weiser, M. R.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • MET and HGF predict outcome in colorectal cancer
    Meeting Abstract

    Kammula, U. S.; Kuntz, E.; Zeng, Z. S.; Shia, J. R.; Landmann, R.; Paty, P.; Weiser, M.
    Journal of the American College of Surgeons (2004)

    Fulltext@MSK | Save
  • INI1 expression distinguishes atypical teratoid/rhabdoid tumor (AT/RT) from choroid plexus carcinoma (CPC)
    Meeting Abstract

    Judkins, A. R.; Burger, P.; Hamilton, R. L.; Kleinschmidt-DeMasters, B.; Perry, A.; Pomeroy, S.; Rosenblum, M. K.; Yachnis, A. T.; Rorke, L. B.; Biegel, J. A.
    Journal of Neuropathology and Experimental Neurology (2004)

    Fulltext@MSK | Save
  • Activity of gemcitabine plus docetaxel in leiomyosarcoma (LMS) and other histologies: Report of an expanded phase II trial
    Meeting Abstract

    Hensley, M. L.; Anderson, S.; Soslow, R.; Antonescu, C.; Upham, T.; Riedel, E.; Aghajanian, C.; Maki, R. G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Desmoplastic melanoma: A pathologically and clinically distinct form of cutaneous melanoma B
    Meeting Abstract

    Hawkins, W. G.; Busam, K. J.; BenPorat, L.; Panageas, K.; Coit, D. G.; Gyorki, D. E.; Linehan, D. C.; Brady, M. S.
    Annals of Surgical Oncology (2004)

    Fulltext@MSK | Save
  • Phase II trial of erlotinib (OSI-774), an epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor, and bevacizumab, a recombinant humanized monoclonal antibody to vascular endothelial growth factor (VEGF), in patients (pts) with metastatic breast cancer (MBC)
    Meeting Abstract

    Dickler, M.; Rugo, H.; Caravelli, J.; Brogi, E.; Sachs, D.; Panageas, K.; Flores, S.; Moasser, M.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Clinical assessment following preoperative combined modality therapy (CMT) for rectal carcinoma does not accurately predict pathologic response: A prospective analysis
    Meeting Abstract

    Chessin, D. B.; Shia, J.; Mazumdar, M.; Moore, H. G.; Paty, P.; Saltz, L.; Minsky, B.; Cohen, A. M.; Wong, W. D.; Guillem, J. G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • High-grade neuroendocrine carcinomas of the gastrointestinal tract: The Memorial Sloan-Kettering Cancer Center experience of 143 cases
    Meeting Abstract

    Brenner, B.; Shia, J.; Klimstra, D. S.; Gonen, M.; Shah, M. A.; Leonard, G. D.; Kelsen, D. P.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Inactivation of INI1 distinguishes CNS rhabdoid tumor from choroid plexus carcinoma
    Meeting Abstract

    Biegel, J. A.; Burger, P.; Hamilton, R. L.; Kleinschmidt-DeMasters, B.; Perry, A.; Pomeroy, S.; Rosenblum, M. K.; Yachnis, A. T.; Rorke, L. B.; Judkins, A. R.
    Cytogenetic and Genome Research (2004)

    Fulltext@MSK | Save